Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: pegfilgrastim|DRUG: docetaxel|DRUG: epirubicin hydrochloride
Sponsor: NCIC Clinical Trials Group